Weak: only small or nonrandomized trials available; Unknown: not enough data to determine benefit. ERA: Endothelin receptor antagonist; PDE5: Phosphodiesterase type 5; PH: Pulmonary hypertension.

A recent publication in the International Journal of Cardiology, "Pulmonary artery denervation in pulmonary hypertension: A ...

Since many of the observed benefits of PDE5 inhibition with regard to left ventricular hypertrophy, ventricular-vascular stiffening, renal dysfunction, and pulmonary hypertension may be ...

Pulmonary hypertension (PH ... case of Opsumit (macitentan), Tracleer (bosentan), and Letairis (ambrisentan). Phosphodiesterase-5 (PDE-5) inhibitors enhance the effects of nitric oxide in the ...

Pulmonary arterial hypertension (PAH) is a rare form of pulmonary hypertension. It occurs because progressive vascular ...

Pulmonary hypertension is a common consequence of interstitial lung disease (PH-ILD), with the highest rate seen among ...

Pulmonary arterial hypertension is caused by narrowing of the blood vessels in the lungs. Learn how it happens, including ...

PDE5 inhibitors work by blocking an enzyme ... Revatio is prescribed for people with pulmonary arterial hypertension (PAH) to ...

A small, multi-country analysis of women of child-rearing age has found that these patients experience limits on activities ...

Viagra inhibits PDE5 and acts as a vasodilator (something ... of their validity. Pulmonary arterial hypertension (PAH) is a serious condition that happens when the tiny vessels in your lungs ...

Are you searching for effective medications to treat 'Pulmonary Arterial Hypertension'? This comprehensive guide provides the latest information on medications-both generic and branded-that are ...